Cell Signaling Technology

Product Pathways - Angiogenesis

Thrombospondin-1 Antibody #14778


No. Size Price
14778S 100 µl ( 10 western blots ) ¥3,100.00 现货查询 购买询价
14778 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse,Rat, Endogenous 170 Rabbit

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting,

Specificity / Sensitivity

Thrombospondin-1 Antibody recognizes endogenous levels of total thrombospondin-1 protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser670 of human thrombospondin-1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from ACHN, LN18, and mIMCD-3 cell lines using Thrombospondin-1 Antibody.


The adhesive glycoprotein thrombospondin-1 (THBS1, TSP1) localizes to the extracellular matrix (ECM) and mediates interactions between cells and the ECM and among cells. Thrombospondin-1 is a multi-domain, glycosylated protein that interacts with a wide variety of extracellular targets, including matrix metalloproteinases (MMPs), collagens, cell receptors, growth factors, and cytokines (1). The protein structure of THBS1 includes an amino-terminal laminin G-like domain, a von Willebrand factor-binding domain, and multiple thrombospondin (TSP) repeated sequences designated as type I, type II, or type III repeats. Each thrombospondin domain interacts with a distinct type of cell surface ligands or protein targets. The amino-terminal domain interacts with aggrecan, heparin, and integrin proteins. Type I TSP repeats interact with MMPs and CD36, while carboxy-terminal repeats bind the thrombospondin receptor CD47 (1). Through these interactions, THBS1 exerts diverse effects on different signaling pathways, such as VEGF receptor/NO signaling, TGFβ signaling, and the NF-κB pathway (2-5). Thrombospondin-1 is an important regulator of many biological processes, including cell adhesion/migration, apoptosis, angiogenesis, inflammation, vascular function, and cancer development (2-5). The activity of thrombospondin-1 is mainly regulated by extracellular proteases. The metalloproteinase ADAMTS1 cleaves thrombospondin, resulting in the release of peptides with anti-angiogenic properties. Elastase and plasmin proteases degrade the THBS1 protein and down regulate its activity (6). As THBS1 is an important protein inhibitor of angiogenesis, the development of thrombospondin-based compounds and their use in therapeutic studies may provide a beneficial approach to the treatment of cancer (7,8).

  1. Resovi, A. et al. (2014) Matrix Biol 37, 83-91.
  2. Lawler, P.R. and Lawler, J. (2012) Cold Spring Harb Perspect Med 2, a006627.
  3. Lopez-Dee, Z. et al. (2011) Mediators Inflamm 2011, 296069.
  4. Roberts, D.D. et al. (2012) Matrix Biol 31, 162-9.
  5. Kazerounian, S. et al. (2008) Cell Mol Life Sci 65, 700-12.
  6. Iruela-Arispe, M.L. (2008) Curr Drug Targets 9, 863-8.
  7. Mirochnik, Y. et al. (2008) Curr Drug Targets 9, 851-62.
  8. Taraboletti, G. et al. (2010) Oncotarget 1, 662-73.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Tween is a registered trademark of ICI Americas, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :